Norway · Delayed Price · Currency is NOK Lytix Biopharma AS Statistics
Total Valuation
OSL:LYTIX has a market cap or net worth of NOK 498.31 million. The enterprise value is 400.71 million.
| Market Cap | 498.31M |
| Enterprise Value | 400.71M |
Important Dates
The next estimated earnings date is Tuesday, November 18, 2025.
| Earnings Date | Nov 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OSL:LYTIX has 68.26 million shares outstanding. The number of shares has increased by 54.99% in one year.
| Current Share Class | 68.26M |
| Shares Outstanding | 68.26M |
| Shares Change (YoY) | +54.99% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 3.28% |
| Owned by Institutions (%) | 17.07% |
| Float | 33.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 819.59 |
| PB Ratio | 5.54 |
| P/TBV Ratio | 5.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.52 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.85, with a Debt / Equity ratio of 0.03.
| Current Ratio | 5.85 |
| Quick Ratio | 5.85 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -317.43 |
Financial Efficiency
Return on equity (ROE) is -97.33% and return on invested capital (ROIC) is -59.94%.
| Return on Equity (ROE) | -97.33% |
| Return on Assets (ROA) | -49.44% |
| Return on Invested Capital (ROIC) | -59.94% |
| Return on Capital Employed (ROCE) | -80.96% |
| Revenue Per Employee | 76,000 |
| Profits Per Employee | -9.08M |
| Employee Count | 7 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.99% in the last 52 weeks. The beta is -0.44, so OSL:LYTIX's price volatility has been lower than the market average.
| Beta (5Y) | -0.44 |
| 52-Week Price Change | +23.99% |
| 50-Day Moving Average | 7.82 |
| 200-Day Moving Average | 7.09 |
| Relative Strength Index (RSI) | 46.50 |
| Average Volume (20 Days) | 32,163 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OSL:LYTIX had revenue of NOK 608,000 and -72.63 million in losses. Loss per share was -1.10.
| Revenue | 608,000 |
| Gross Profit | 608,000 |
| Operating Income | -74.28M |
| Pretax Income | -72.63M |
| Net Income | -72.63M |
| EBITDA | -74.22M |
| EBIT | -74.28M |
| Loss Per Share | -1.10 |
Balance Sheet
The company has 100.26 million in cash and 2.66 million in debt, giving a net cash position of 97.61 million or 1.43 per share.
| Cash & Cash Equivalents | 100.26M |
| Total Debt | 2.66M |
| Net Cash | 97.61M |
| Net Cash Per Share | 1.43 |
| Equity (Book Value) | 90.02M |
| Book Value Per Share | 1.32 |
| Working Capital | 89.16M |
Cash Flow
| Operating Cash Flow | -63.54M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -12,216.94% |
| Pretax Margin | -11,946.05% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OSL:LYTIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -54.99% |
| Shareholder Yield | -54.99% |
| Earnings Yield | -14.58% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |